Pro-Dex Q4 Revenue Jumps 17% to $20.4M; Gross Margin Doubles to 35%
PDEX has more than doubled off its 52-week low of $23.47.
Summary
Pro-Dex reported fiscal Q4 revenue of $20.4 million, up 17% year-over-year and ahead of consensus, with gross margin doubling to 35%. Full-year net income rose 52% to $13.7 million, and cash jumped to $8.2 million from $419K.
Key Events · Earnings and Guidance · PDEX
-
Q4 Revenue Beats Consensus
Net sales rose 17% to $20.4 million, exceeding the $19.2 million single-analyst estimate, driven by the largest customer's next-generation orthopedic handpiece.
-
Gross Margin Doubles to 35%
Q4 gross profit increased 103% to $7.1 million, lifting gross margin from 20% to 35% on favorable product mix and APM contribution.
-
Full-Year Net Income Up 52%
Fiscal 2026 net income reached $13.7 million ($4.12 diluted EPS) versus $9.0 million ($2.67) in fiscal 2025, including $5.7 million in volatile investment gains.
-
Cash Position Transformed
Cash and equivalents grew to $8.2 million from $419K a year earlier, with operating cash flow swinging to positive $7.2 million from negative $1.7 million.
Analysis · PDEX · Industrial Applications And Services
Pro-Dex closed fiscal 2026 with accelerating momentum. Q4 net sales rose 17% to $20.4 million, beating the single-analyst consensus of $19.2 million, while gross margin expanded from 20% to 35% — a 15-point swing driven by the next-generation orthopedic handpiece ramp and the APM acquisition. Full-year net income reached $13.7 million, or $4.12 per diluted share, up from $9.0 million a year earlier. The balance sheet strengthened dramatically: cash grew from $419K to $8.2 million, and operating cash flow swung from negative $1.7 million to positive $7.2 million. The one caveat: $5.7 million of full-year net income came from gains on marketable equity investments, which management itself flags as highly volatile.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 30.1% of the 2014 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.11%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PDEX was trading at $65.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $197.2M. The 52-week trading range was $23.47 to $69.86. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.